In addition, growth factors promote AKT-ACLY signaling and histone H3 acetylation in PDAC cells, and a combination of the bromodomain inhibitor JQ1 and statins was shown to inhibit both PDAC cell proliferation and tumor growth [166]. The gene discussed is ACLY; the disease is neoplasm.